leisure time -WSS

leisure time

author：fashion 2025-08-23 08:54:48 - browse：9

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Burning questions for the 2024 JPM Healthcare Conference

hotspot

WSS

A single drug, study failures leave Anavex with nothing but cash

J&J to buy cancer drug developer Ambrx Biopharma

When is a doctor not a doctor? Try when patients address women doctors

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Make 'food is medicine' a key part of White House nutrition meeting

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

focus

leisure time

leisure time

Drug repurposing or repositioning? The language matters

When is a doctor not a doctor? Try when patients address women doctors

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Sports medicine is finally prioritizing gender equality

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

New air purifier tech could be key to improving indoor air quality

4th of July breaks record for highest global temperature ever measured

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

focus

Pfizer's Covid pill remains 89% effective in final analysis, company says

3 trends to watch in health tech's hiring outlook for 2024

Listen: Biogen's messy board & Laronde's data problem

RaDonda Vaught case: a double standard for nurses, physicians

Why is France rioting? What to know about the fatal police shooting of Nahel M

J&J to buy cancer drug developer Ambrx Biopharma

entertainment

hotspot

leisure time

focus